Pursuant to Regulation 30 of SEBI LODR REGULATIONS, 2015 readwith Para A of Part A of Schedule III and SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015, we wish to inform you that ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences Ltd (BSE: 530057) has informed the stock exchange that shareholders at the 43rd Annual General Meeting held on 25 September 2025 approved a special resolution to expand the company's main objects clause. A new sub-clause 6 has been inserted into Clause III(A) of the Memorandum of Association, adding a very wide range of new business areas beyond its existing biosciences focus. The new permitted activities include agro and agro-based products, solar and renewable energy equipment, power and infrastructure projects, land development and real estate, drones, IT and software development, data centers, cloud facilities, servers and storage systems. The company will also have powers for contract manufacturing, EPC, turnkey projects, O&M, R&D, consultancy, collaborations, licensing, franchises and joint ventures in India and abroad. The amended MoA will be filed with the Registrar of Companies in due course.
This is a major diversification move that takes the company far beyond its core biosciences identity into sectors like solar energy, real estate, IT, data centers and drones. For shareholders, it opens up new growth avenues but also raises questions about strategic focus, and any tangible benefits will depend on actual execution and capital deployment.